Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorErzurum Regional Training & Research Hospital

About this trial

Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Between 18-50 years

Cesarean Section

Disqualifiers

Cesarean Section under general anesthesia

emergency cases

those with a body mass index greater than 35 kg/m2

coagulopathy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Bupivacaine 0.25% Injectable Solution

    Drug

    Ultrasound-guided block with 20 ml %0.25 bupivacaine, per side

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Group ESPActive comparator 1 intervention
Group B: Group TFPActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Opioid Consumption

Opioid consumption postroperative period

Time frame
Postoperative first 24 hours

Secondary outcomes

1

Visual Analog Pain Score

Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Time frame
Postoperative first 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: